Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Sophia T. Tan, Ada Kwan, Isabel Rodríguez-Barraquer, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 358-365
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

The Epidemiology of Long Coronavirus Disease in US Adults
McKaylee Robertson, Saba A Qasmieh, Sarah Kulkarni, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 9, pp. 1636-1645
Open Access | Times Cited: 75
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 48
SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
José L. Gonzáles, Denise A. Marston
EFSA Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 46
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 19
The Real Cost of Political Polarization: Evidence from the COVID-19 Pandemic
Brandice Canes‐Wrone, Jonathan Rothwell, Christos Makridis
SSRN Electronic Journal (2020)
Closed Access | Times Cited: 103
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 55
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 39
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 35
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 34
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Nationwide health, socio-economic and genetic predictors of COVID-19 vaccination status in Finland
Tuomo Hartonen, Bradley Jermy, Hanna Sõnajalg, et al.
Nature Human Behaviour (2023) Vol. 7, Iss. 7, pp. 1069-1083
Open Access | Times Cited: 31
Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection
Denis Mongin, Nils Bürgisser, Gustavo Laurie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
Pablo N. Perez‐Guzman, Edward Knock, Natsuko Imai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
Hailey J. Park, Gregg Gonsalves, Sophia T. Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Ruth Drury, Susana Camara, Irina Chelysheva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 10
Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity
Sophia T. Tan, Isabel Rodríguez-Barraquer, Ada Kwan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Margaret L. Lind, Murilo Dorión, Amy J. Houde, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?
Renata Gili, Roberto Burioni
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection
Christian Devaux, Laurence Camoin‐Jau
Viruses (2023) Vol. 15, Iss. 5, pp. 1045-1045
Open Access | Times Cited: 20
Promises and challenges of mucosal COVID-19 vaccines
Abhay P. S. Rathore, Ashley L. St. John
Vaccine (2023) Vol. 41, Iss. 27, pp. 4042-4049
Open Access | Times Cited: 18
Effects of public-health measures for zeroing out different SARS-CoV-2 variants
Yong Ge, Xilin Wu, Wenbin Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review
Anouk Oordt-Speets, Júlia Spinardi, Carlos Mendoza, et al.
COVID (2023) Vol. 3, Iss. 10, pp. 1516-1527
Open Access | Times Cited: 18
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19
Beatrice Dallan, Davide Proietto, Martina De Laurentis, et al.
Nature Aging (2024) Vol. 4, Iss. 8, pp. 1121-1136
Open Access | Times Cited: 8
A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
Hongwei Shen, Dingqiang Chen, Chenglin Li, et al.
Health Science Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top